Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
- PMID: 33200431
- PMCID: PMC7753548
- DOI: 10.1002/jmv.26672
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
Conflict of interest statement
The authors declare that there are no conflict of interests.
Comment on
-
The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.J Med Virol. 2021 Mar;93(3):1370-1377. doi: 10.1002/jmv.26625. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33095513
Similar articles
-
Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.Ann Intern Med. 2021 Jan;174(1):W17. doi: 10.7326/L20-1355. Epub 2020 Dec 1. Ann Intern Med. 2021. PMID: 33253036 Free PMC article. No abstract available.
-
The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients.J Renin Angiotensin Aldosterone Syst. 2021 Jan-Dec;22(1):1470320320987118. doi: 10.1177/1470320320987118. J Renin Angiotensin Aldosterone Syst. 2021. PMID: 33412991 Free PMC article. No abstract available.
-
Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.Ann Intern Med. 2020 Dec 15;173(12):167-168. doi: 10.7326/L20-1293. Epub 2020 Oct 27. Ann Intern Med. 2020. PMID: 33105094 Free PMC article. No abstract available.
-
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.JAMA Netw Open. 2021 Mar 1;4(3):e213594. doi: 10.1001/jamanetworkopen.2021.3594. JAMA Netw Open. 2021. PMID: 33787911 Free PMC article.
-
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095. doi: 10.1016/j.jacc.2020.04.028. Epub 2020 Apr 16. J Am Coll Cardiol. 2020. PMID: 32305401 Free PMC article. Review.
References
-
- American Heart Association, Professional Heart Daily . HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID‐19. 2020. https://professional.heart.org/professional/ScienceNews/UCM_505836_HFSAA.... Accessed March 20, 2020.
-
- ESC . Position statement of the ESC Council on hypertension on ACE‐inhibitors and angiotensin receptor blockers. 2020. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/pos.... Accessed March 20, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical